Three-Drug shield tested to protect cancer patients after transplant
Disease control
Recruiting now
This study is testing a combination of three medications given after a stem cell transplant to prevent a dangerous complication called graft-versus-host disease (GVHD). It will enroll 124 adults with leukemia or similar blood cancers who are receiving a transplant from a donor. T…
Phase: PHASE2 • Sponsor: Hannah Choe, MD • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC